Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on September 29, 2026

Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
Xanadu and Bluefors Partner to Redefine Cryogenic Infrastructure for Utility-Scale Quantum Computing
Alpha Compute Update on Operating Oil and Gas Assets Due Diligence in Pennsylvania, Securing 300+ Acres Across the Marcellus and Utica Shales
The Engine Plans October 15 Launch of an AI Team That Creates Content and Handles Sales Conversations
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for…
Barrick to Present at Mining Forum Americas
Canada’s Coffee Industry Generates $34.7 Billion in Economic Impact
Miata Intersects 35.25 m at 3.41 g/t Au Including 5.55 m at 15.36 g/t at Jons Trend, Sela Creek, Suriname
Roze AI Inc. Common Shares Expected to Begin Trading on Nasdaq on September 29, 2026
ISG Welcomes Former Liberty Mutual COO James MacPhee to Board of Advisors
Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant
env zero Launches EZ Control, the Autonomous Cloud Control Plane for the AI Era
Wood Mackenzie: Europe's Power Sector Hits 80% Zero-Carbon Generation by 2030, But Misses Its Own Renewables Target
Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
KAYTUS stellt AI Managed Service für Rechenzentren vor
KAYTUS présente son service de gestion de l’IA pour les centres de données
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.